Aclarion, Inc. (NASDAQ:ACONW) Short Interest Up 66.9% in August

Aclarion, Inc. (NASDAQ:ACONW) was the recipient of a large increase in short interest in August. As of August 14th, there was short interest totaling 231,797 shares, an increase of 66.9% from the July 30th total of 138,906 shares. Based on an average daily trading volume, of 54,550 shares, the short-interest ratio is currently 4.2 days.

Aclarion Price Performance

Shares of ACONW opened at $0.03 on Monday. The business’s 50 day moving average price is $0.03 and its 200-day moving average price is $0.03. Aclarion has a 52 week low of $0.02 and a 52 week high of $0.23.

About Aclarion

Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc and changed its name to Aclarion, Inc in December 2021.